Understanding immune cell patterns in severe eczema patients on treatment

This research study is following adults with severe atopic dermatitis (eczema) who are starting treatment with dupilumab, a medication that helps control the immune system. By analyzing blood samples collected at different time points, researchers hope to identify immune cell patterns that can predict which patients will respond best to this treatment—and which may need a different approach.

Currently, doctors cannot easily predict in advance who will benefit most from this medication. By finding specific immune cell markers before treatment starts, this study could help doctors personalize treatment plans and choose the best therapy for each patient from the beginning.